Cargando…

Impact of IL-23 in prostate cancer

Detalles Bibliográficos
Autor principal: Mirlekar, Bhalchandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887111/
https://www.ncbi.nlm.nih.gov/pubmed/34850747
http://dx.doi.org/10.4103/aja2021100
_version_ 1784660824433885184
author Mirlekar, Bhalchandra
author_facet Mirlekar, Bhalchandra
author_sort Mirlekar, Bhalchandra
collection PubMed
description
format Online
Article
Text
id pubmed-8887111
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-88871112022-03-10 Impact of IL-23 in prostate cancer Mirlekar, Bhalchandra Asian J Androl Invited Commentary Wolters Kluwer - Medknow 2021-11-26 /pmc/articles/PMC8887111/ /pubmed/34850747 http://dx.doi.org/10.4103/aja2021100 Text en Copyright: ©The Author(s)(2021) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Invited Commentary
Mirlekar, Bhalchandra
Impact of IL-23 in prostate cancer
title Impact of IL-23 in prostate cancer
title_full Impact of IL-23 in prostate cancer
title_fullStr Impact of IL-23 in prostate cancer
title_full_unstemmed Impact of IL-23 in prostate cancer
title_short Impact of IL-23 in prostate cancer
title_sort impact of il-23 in prostate cancer
topic Invited Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887111/
https://www.ncbi.nlm.nih.gov/pubmed/34850747
http://dx.doi.org/10.4103/aja2021100
work_keys_str_mv AT mirlekarbhalchandra impactofil23inprostatecancer